AU3734793A - Mutant gpibalpha fragments and recombinant expression thereof - Google Patents

Mutant gpibalpha fragments and recombinant expression thereof

Info

Publication number
AU3734793A
AU3734793A AU37347/93A AU3734793A AU3734793A AU 3734793 A AU3734793 A AU 3734793A AU 37347/93 A AU37347/93 A AU 37347/93A AU 3734793 A AU3734793 A AU 3734793A AU 3734793 A AU3734793 A AU 3734793A
Authority
AU
Australia
Prior art keywords
gpibalpha
mutant
fragments
recombinant expression
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37347/93A
Other languages
English (en)
Inventor
Zaverio M. Ruggeri
Jerry L Ware
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU3734793A publication Critical patent/AU3734793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU37347/93A 1992-02-26 1993-02-25 Mutant gpibalpha fragments and recombinant expression thereof Abandoned AU3734793A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84207792A 1992-02-26 1992-02-26
US842077 1992-02-26

Publications (1)

Publication Number Publication Date
AU3734793A true AU3734793A (en) 1993-09-13

Family

ID=25286467

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37347/93A Abandoned AU3734793A (en) 1992-02-26 1993-02-25 Mutant gpibalpha fragments and recombinant expression thereof

Country Status (2)

Country Link
AU (1) AU3734793A (fr)
WO (1) WO1993016712A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA942818B (en) * 1993-04-23 1995-01-30 Bio Technology General Corp Method of enhancing thrombolysis.
JP4380067B2 (ja) * 1998-04-23 2009-12-09 味の素株式会社 抗血栓活性物質及びグリコカリシンの検出法
CA2344606A1 (fr) 1998-10-23 2000-05-04 Huabing Yuan Anticorps anti-facteur de von willebrand specifiques de conformation
US7112661B1 (en) 1998-10-30 2006-09-26 The Research Foundation Of State University Of New York Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha
US6841354B2 (en) * 2000-12-21 2005-01-11 Philadelphia, Health & Education Corporation Screening assay for anti-thrombotic/anti-platelet activity
EP1977766A4 (fr) 2006-01-06 2011-05-25 Univ Keio Materiau de distribution de medicament
DE102007031708A1 (de) 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88308A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor

Also Published As

Publication number Publication date
WO1993016712A1 (fr) 1993-09-02

Similar Documents

Publication Publication Date Title
AU6360394A (en) Vasonatrin peptide and analogs thereof
AU4953793A (en) Multicistronic expression units and their use
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU4156693A (en) Variants of parathyroid hormone and its fragments
AU2075897A (en) Delivery system using mab 3e10 and mutants and/or functional fragments thereof
AU5010793A (en) Human interleukin-13
AU6236894A (en) Method for the improvement of scar size and appearance
AU1914595A (en) Isolated antigenic oncogene peptide fragments and uses
AU1496288A (en) Recombinant ricin toxin fragments
AU6172994A (en) Scalpel and technique for using scalpel
AU6080898A (en) Factor x deletion mutants and analogues thereof
AU4219693A (en) Inter-task buffer and connections
AU633294B2 (en) Motilin-like polypeptide and use thereof
AU5292090A (en) Improved extension chute and connection therefor
AU4519193A (en) Interleukin-1beta deletion mutant
AU1751892A (en) Novel peptide compositions and uses therefor
AU6299594A (en) Recombinant fowlpox virus s-fpv-043 and uses thereof
AU1435695A (en) Recombinant human thymopoietin proteins and uses therefor
AU4055793A (en) Phacoemulsification method and tip
AU4514093A (en) Recombinant antibody against human interleukin-1
AU3734793A (en) Mutant gpibalpha fragments and recombinant expression thereof
AU1714792A (en) Glass composition and use
AU3451397A (en) Modified protein g and fragments thereof
AU4100593A (en) Iminoalcohol-oxazolidine mixtures and their use